Noctura Media Kit

Here you’ll find approved brand assets, company background, key contacts, and useful links for editorial and press purposes.

About Us

Noctura 400 is a pioneering light-based medical technology developed by PolyPhotonix, a bio-photonic research and development company that designs, develops and manufactures non-invasive photonic based medical devices. The Noctura 400 sleep mask is a CE-marked, non-invasive therapy for diabetic retinopathy and diabetic macular oedema. It’s designed to be worn at night while sleeping, helping to manage and slow the progression of sight loss. Learn more about the Noctura 400.

Key Personnel

Richard Kirk is the CEO of PolyPhotonix and the driving force behind Noctura’s groundbreaking light-based therapies. With a diverse background spanning healthcare, technology, and creative industries, Richard has spent over 16 years leading PolyPhotonix to bridge science, innovation, and real-world healthcare impact. Read Richard Kirk’s full bio.

Media Contact

For all media inquiries, interviews, or to request additional assets, please get in touch:

Email: enquiries@polyphotonix.com
Phone: +44 (0) 1740 625 555

Brand Assets

You may use these official logo and product images for editorial use. Please do not alter the logos. For high-res or custom requests, please contact our media team. (Additional high-res images and videos available upon request).

Social Media

Testimonials

Read real stories from patients and healthcare professionals about their experience with Noctura.
See testimonials